Inventor · disambiguated record
Hironori Nakagami
Also filed as: NAKAGAMI HIRONORI
17 granted patents·18 pending applications·27 citations·filing 2005–2024
90Inventor score
Top patents by PatentIndex Score
35 records- 0188US10112978B2Peptide and use thereofUNIV OSAKA·Filed 2015·Granted Oct 30, 2018·4 cites·20 claims
- 0288US2025090634A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2024·Application pending·0 cites
- 0383US7807176B2Polypeptide promoting vascular endothelial cell growthGENOMIDEA INC·Filed 2005·Granted Oct 5, 2010·6 cites·9 claims
- 0482US10517926B2Oligopeptide having proinflammatory cytokine secretion-inhibiting activityUNIV OSAKA·Filed 2016·Granted Dec 31, 2019·3 cites·8 claims
- 0580US10980876B2Conjugate vaccine targeting a disease-causing biological proteinUNIV OSAKA·Filed 2017·Granted Apr 20, 2021·1 cites·10 claims
- 0680US9913886B2DNA vaccine containing specific epitope of apolipoprotein (a)ANGES INC·Filed 2016·Granted Mar 13, 2018·5 cites·22 claims
- 0779US9872825B2Peptide with anti-aging effect and use thereofUNIV OSAKA·Filed 2014·Granted Jan 23, 2018·4 cites·23 claims
- 0876US11819537B2Preventive or therapeutic method for inflammatory skin diseaseUNIV OSAKA·Filed 2017·Granted Nov 21, 2023·1 cites·9 claims
- 0973US2022088141A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2021·Application pending·0 cites
- 1071US9446120B2DNA vaccineMORISHITA RYUICHI·Filed 2012·Granted Sep 20, 2016·1 cites·11 claims
- 1170US10543261B2DNA vaccine containing VEGF-specific epitope and/or angiopoietin-2-specific epitopeUNIV OSAKA·Filed 2013·Granted Jan 28, 2020·1 cites·18 claims
- 1269US12070498B2Conjugate vaccine targeting a disease-causing biological proteinUNIV OSAKA·Filed 2021·Granted Aug 27, 2024·0 cites·9 claims
- 1368US10695420B2DNA-peptide combination vaccineANGES INC·Filed 2015·Granted Jun 30, 2020·1 cites·14 claims
- 1468US2011160132A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2006·Application pending·0 cites
- 1566US2019321444A1Lymphangiogenesis-promoting agentsANGES INC·Filed 2019·Application pending·0 cites
- 1664US10233215B2Peptide and use thereofUNIV OSAKA·Filed 2018·Granted Mar 19, 2019·0 cites·8 claims
- 1764US2025177504A1Prorenin receptor peptide, conjugate, and pharmaceutical compositionUNIV KAGAWA NAT UNIV CORP·Filed 2023·Application pending·0 cites
- 1863US2025057928A1Vaccine composition for inducing anti-il-23 antibodyUNIV OSAKA·Filed 2022·Application pending·0 cites
- 1961US11712466B2Vaccine compositionUNIV TOHOKU·Filed 2018·Granted Aug 1, 2023·0 cites·12 claims
- 2056US2016271219A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2016·Application pending·0 cites
- 2156US2023374103A1Wnt SIGNALING PATHWAY INHIBITORUNIV OSAKA·Filed 2021·Application pending·0 cites
- 2255US11421025B2Treatment of IL-17A diseasesUNIV OSAKA·Filed 2014·Granted Aug 23, 2022·0 cites·19 claims
- 2355US2023330214A1Improved dna vaccine for sars-cov-2UNIV OSAKA·Filed 2021·Application pending·0 cites
- 2454US11020464B2Immunogenic composition targeting S100A9UNIV OSAKA·Filed 2018·Granted Jun 1, 2021·0 cites·20 claims
- 2554US10463592B2Peptide with anti-aging effect and use thereofUNIV OSAKA·Filed 2017·Granted Nov 5, 2019·0 cites·24 claims
- 2653US2023310561A1Immunogenic composition targeting phosphorylated tau proteinUNIV OSAKA·Filed 2021·Application pending·0 cites
- 2752US2009082411A1Pharmaceutical for prevention or treatment of bone metabolic diseaseMORISHITA RYUUICHI·Filed 2006·Application pending·0 cites
- 2851US2008312145A1Agent for Regulating Bone FormationANGES MG INC·Filed 2005·Application pending·0 cites
- 2949US2016193308A1Dpp-4-targeting vaccine for treating diabetesUNIV OSAKA·Filed 2014·Application pending·0 cites
- 3047US2022267374A1Immunity inducer and pharmaceutical composition for preventing or treating aging-related diseasesJUNTENDO EDUCATIONAL FOUND·Filed 2020·Application pending·0 cites
- 3147US2012046327A1Method for inhibiting the induction and formation of osteoclastsMORISHITA RYUUICHI·Filed 2011·Application pending·0 cites
- 3247US2010105762A1Therapeutic agent for periodontal disease and alveolar bone loss due to surgeryMORISHITA RYUICHI·Filed 2008·Application pending·0 cites
- 3346US2014086944A1DNA VACCINE CONTAINING SPECIFIC EPITOPE OF APOLIPOPROTEIN (a)ANGESMG INC·Filed 2013·Application pending·0 cites
- 3444US9186439B2Drug-eluting catheter and method of manufacturing the sameMORISHITA RYUICHI·Filed 2009·Granted Nov 17, 2015·0 cites·25 claims
- 3544US2010311823A1Agent for regulating bone formationANGES MG INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hironori Nakagami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →